title: Differential mRNA expression levels of human  histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia.
abstract: Histone modification enzymes regulate gene expression by altering the accessibility of promoters to transcription factors. We sought to determine whether the genes encoding histone modification enzymes are dysregulated in pediatric acute lymphoblastic leukemia (ALL). A real-time PCR array was designed, tested and used to profile the expression of 85 genes encoding histone modification enzymes in bone marrow mononuclear cells from 30 pediatric ALL patients and 20 normal controls. The expression profile of histone-modifying genes was significantly different between normal karyotype B cell pediatric ALL and normal controls. Eleven genes were upregulated in pediatric ALL, including the histone deacetylases HDAC2 and PAK1, and seven genes were downregulated, including PRMT2 and the putative tumor suppressor EP300. Future studies will seek to determine whether these genes serve as biomarkers of pediatric ALL. Ingenuity Pathway Analysis revealed that Gene Expression and Organ Morphology was the highest rated network, with 13 focus molecules (significance score = 35). Ingenuity Pathway Analysis also indicated that curcumin and miR-34 are upstream regulators of histone-modifying enzymes; future studies will seek to validate these results and examine the role of curcumin and miR-34 in leukemia. This study provides new clues into the molecular mechanisms of pediatric ALL.
authors: Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou 215003, Jiangsu, China. panjian2008@163.com.
authors: Yan-Fang
authors: YF
authors: Tao
authors: Li
authors: L
authors: Pang
authors: Xiao-Juan
authors: XJ
authors: Du
authors: Li-Chao
authors: LC
authors: Sun
authors: Shao-Yan
authors: SY
authors: Hu
authors: Jun
authors: J
authors: Lu
authors: Lan
authors: L
authors: Cao
authors: Wen-Li
authors: WL
authors: Zhao
authors: Xing
authors: X
authors: Feng
authors: Jian
authors: J
authors: Wang
authors: Dong
authors: D
authors: Wu
authors: Na
authors: N
authors: Wang
authors: Jian
authors: J
authors: Ni
authors: Jian
authors: J
authors: Pan
references: Mol Cell Endocrinol. 2008 Nov 25;295(1-2):70-8
references: 18755239
references: Nat Rev Cancer. 2007 Nov;7(11):823-33
references: 17957188
references: Cell Mol Life Sci. 2011 Nov;68(21):3557-71
references: 21909785
references: Cancer Res. 2006 Jun 15;66(12):6271-9
references: 16778203
references: FEBS J. 2010 Apr;277(8):1832-42
references: 20236310
references: Brief Funct Genomic Proteomic. 2004 Feb;2(4):334-43
references: 15163368
references: Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6
references: 18755897
references: Br J Cancer. 2008 Mar 25;98(6):1132-40
references: 18283314
references: Biofactors. 2013 Jan-Feb;39(1):37-55
references: 22996381
references: Urol Oncol. 2013 Nov;31(8):1770-9
references: 22944197
references: Nat Genet. 2000 Mar;24(3):300-3
references: 10700188
references: Cell Death Differ. 2010 Feb;17(2):193-9
references: 19461653
references: Front Genet. 2012 May 30;3:94
references: 22666228
references: Clin Sci (Lond). 2012 Aug 1;123(3):161-71
references: 22364258
references: FEBS J. 2009 Mar;276(6):1629-40
references: 19220463
references: Mol Cell Biol. 2006 May;26(10):3864-74
references: 16648481
references: Wiad Lek. 2009;62(3):149-52
references: 20229709
references: Biochim Biophys Acta. 2009 Jan;1789(1):58-68
references: 18722564
references: Pediatr Rep. 2011 Jun 22;3 Suppl 2:e2
references: 22053278
references: Anticancer Res. 2011 Dec;31(12):4115-25
references: 22199269
references: Int J Cancer. 2002 Nov 10;102(2):137-41
references: 12385008
references: BMC Genomics. 2008 Jul 11;9:328
references: 18620571
references: J Am Chem Soc. 2011 Jun 22;133(24):9451-6
references: 21585201
references: FEBS J. 2012 Jan;279(2):316-35
references: 22093364
references: J Cell Biol. 2003 May 12;161(3):583-92
references: 12732616
references: AAPS J. 2009 Sep;11(3):495-510
references: 19590964
references: Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11157-62
references: 21690391
references: Exp Cell Res. 2007 Jul 1;313(11):2356-66
references: 17466295
references: Prog Drug Res. 2011;67:107-24
references: 21141727
references: Semin Hematol. 2009 Jan;46(1):1-2
references: 19100362
references: Curr Opin Struct Biol. 2010 Dec;20(6):739-48
references: 20970991
references: Molecules. 2011 Jun 03;16(6):4567-98
references: 21642934
references: Int J Cancer. 2010 Jul 1;127(1):21-31
references: 19876919
references: PLoS One. 2011;6(11):e28103
references: 22132221
references: Epigenetics. 2011 Sep 1;6(9):1059-67
references: 21847010
references: Brain Res. 2010 May 6;1329:1-9
references: 20211609
references: Cancer Cell Int. 2012 Sep 08;12(1):40
references: 22958424
references: Chembiochem. 2011 Jan 24;12(2):290-8
references: 21243716
references: BMC Med Genomics. 2009 Jun 23;2:36
references: 19549311
references: Chin J Cancer. 2010 Jul;29(7):649-54
references: 20591216
references: Fertil Steril. 2010 Aug;94(3):1125-8
references: 20079895
references: Fertil Steril. 2011 Aug;96(2):508-11
references: 21722895
references: J Cell Mol Med. 2009 May;13(5):826-52
references: 19175682
references: BMC Cancer. 2010 Apr 28;10:164
references: 20426825
references: Epigenomics. 2011 Feb;3(1):83-92
references: 22126155
references: Cell Cycle. 2009 Mar 1;8(5):712-5
references: 19221490
references: PLoS One. 2011;6(8):e24023
references: 21886846
references: Oncogene. 2011 Aug 4;30(31):3391-403
references: 21516126
references: Int J Cancer. 2009 Dec 1;125(11):2511-9
references: 19610058
references: Oncogene. 2012 Feb 23;31(8):1001-12
references: 21822311
references: Br J Haematol. 2010 Sep;150(6):665-73
references: 20636436
references: Genes Chromosomes Cancer. 2003 Jun;37(2):121-31
references: 12696060
references: Cancer Cell. 2004 May;5(5):455-63
references: 15144953